| HOME >> MEDICINE >> TECHNOLOGY |
Small versus big companies .. 278
Expansion in proteomics according to area of application . 278
Growth trends in cell-based protein assay market .. 279
Challenges for development of cell-based protein assays .. 279
Future trends and prospects of cell-based protein assays .. 279
Strategic collaborations .. 280
Analysis of proteomics collaborations according to types of companies . 280
Types of proteomic collaborations . 281
Proteomics collaborations according to application areas 281
Analysis of proteomics collaborations: types of technologies . 281
Collaborations based on protein biochip technology . 282
Concluding remarks about proteomic collaborations 282
Proteomic patents . 283
Market drivers in proteomics . 283
Needs of the pharmaceutical industry . 283
Need for outsourcing proteomic technologies 284
Funding of proteomic companies and research . 284
Technical advances in proteomics 284
Changing trends in healthcare in future . 285
Challenges facing proteomics 285
Magnitude and complexity of the task. 285
Technical challenges . 285
Limitations of proteomics 286
Limitations of 2DGE 286
Limitations of mass spectrometry techniques . 286
Complexity of the pharmaceutical proteomics 286
Unmet needs in proteomics 287
11. Future of Proteomics 288
Genomics to proteomics .. 288
Faster technologies .. 288
FLEXGene repository 288
Need for new proteomic technologies 289
Emerging proteomic technologies 290
Detection of alternative protein isoforms 290
Direct protein identification in large genomes by mass spectrometry 290
Proteome identification kits with stacked membranes 290
Vacuum deposition interface.. 291
In vitro protein biosynthesis .. 291
<| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |